回复lxdongzi2003发表于:2020/9/23 14:58:18悬赏金额:
10积分 状态:
未解决
【序号】:1
【作者】:Xiaowei Qian, Hongxia Dong, Hong Tian, Yue Tong, Linfeng Guo, Xiaojing Hu, Xiangdong Gao, , Wenbing Yao
【题名】:Characterization of a site-specific PEGylated analog of exendin-4 and determination of the PEGylation site
【期刊】:International Journal of Pharmaceutics
【年、卷、期、起止页码】:Volume 454, Issue 1, 15 September 2013, Pages 553–558
【全文链接】:http://www.sciencedirect.com/science/article/pii/S0378517313005772
【序号】:2
【作者】:Pan LQ, Wang HB, Lai J, Xu YC, Zhang C, Chen SQ.
【题名】:Site-specific PEGylation of a mutated-cysteine residue and its effect on tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL).
【期刊】:Biomaterials.
【年、卷、期、起止页码】: 2013 Dec;34(36):9115-23. doi: 10.1016/j.biomaterials.2013.08.020. Epub 2013 Aug 24.
【全文链接】:http://www.ncbi.nlm.nih.gov/pubmed/23981355
【序号】:3
【作者】:Zhang C, Yang XL, Yuan YH, Pu J, Liao F.
【题名】:Site-specific PEGylation of therapeutic proteins via optimization of both accessible reactive amino acid residues and PEG derivatives.
【期刊】:BioDrugs
【年、卷、期、起止页码】: 2012 Aug 1;26(4):209-15. doi: 10.2165/11633350-000000000-00000
【全文链接】:
【序号】:4
【作者】:Sala A, Ehrbar M, Trentin D, Schoenmakers RG, V?r?s J, Weber FE
【题名】:Enzyme mediated site-specific surface modification.
【期刊】:Langmuir
【年、卷、期、起止页码】: 2010 Jul 6;26(13):11127-34. doi: 10.1021/la1008895
【全文链接】:
【序号】:5
【作者】:Gao M, Jin Y, Tong Y, Tian H, Gao X, Yao W.
【题名】:A site-specific PEGylated analog of exendin-4 with improved pharmacokinetics and pharmacodynamics in vivo.
【期刊】:J Pharm Pharmacol.
【年、卷、期、起止页码】:2012 Nov;64(11):1646-53. doi: 10.1111/j.2042-7158.2012.01545.x. Epub 2012 Jun 4.
【全文链接】:http://www.ncbi.nlm.nih.gov/pubmed/23058052